allergy vaccine (Acambis/GlaxoSmithKline)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameallergy vaccine (Acambis/GlaxoSmithKline)
Drug Alias Nameallergy vaccine (Peptide Therapeutics/SmithKline Beecham)anti-IgE vaccine (Acambis/GlaxoSmithKline)asthma vaccine (Acambis/GlaxoSmithKline)asthma vaccine (Peptide Therapeutics/SmithKline Beecham)anti-IgE vaccine (Peptide Therapeutics/SmithKline Beecham)
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcambis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcambisGlaxosmithkline PlcSmithkline Beecham Plc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A